{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T04:10:34Z","timestamp":1722744634518},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lyme disease is the most common tick-borne illness in the USA, Canada, and Europe. Clinical manifestations vary greatly, with localized skin findings functioning as early signs of the disease, followed by disseminated disease. The rarest dermatologic presentation of Lyme is a borrelial lymphocytoma, occurring distinctly in Europe and caused typically by<jats:italic>Borrelia afzelii<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a Caucasian 5-year-old European-American boy with slowly progressing, painless edema and erythema of his right pinna. Travel history revealed significant exposure to ticks during a recent trip to Eastern Europe. Laboratory testing for<jats:italic>Borrelia burgdorferi<\/jats:italic>demonstrated mixed positivity. He was treated with a 21-day course of amoxicillin, with complete resolution of symptoms and no sign of secondary Lyme disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Borrelial lymphocytoma is a rare manifestation of Lyme disease in North America, although not uncommon in Europe. Diagnosis is made by the presence of a painless erythematous swelling typically found on the ear lobe, nipples, or testes. Laboratory tests are available but with low sensitivity, therefore, a high index of suspicion is necessary for a clinical diagnosis to be made. Treatment for isolated borrelial lymphocytoma is doxycycline 4\u2009mg\/kg up to 100\u2009mg twice daily, whereas for children less than 8\u2009years of age amoxicillin 50\u2009mg\/kg divided three times daily, for 3\u20134\u2009weeks, is preferred.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-020-02377-x","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T23:06:18Z","timestamp":1586991978000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A painless erythematous swelling of the external ear as a manifestation of Lyme disease: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Allison","family":"Remiker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodosia A.","family":"Kalfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"18","key":"2377_CR1","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMcp1314325","volume":"370","author":"ED Shapiro","year":"2014","unstructured":"Shapiro ED. Lyme disease. N Engl J Med. 2014;370(18):1724\u201331.","journal-title":"N Engl J Med"},{"key":"2377_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461\u201373.","journal-title":"Lancet."},{"issue":"5","key":"2377_CR3","first-page":"296","volume":"14","author":"RR M\u00fcllegger","year":"2004","unstructured":"M\u00fcllegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol. 2004;14(5):296\u2013309.","journal-title":"Eur J Dermatol"},{"key":"2377_CR4","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1542\/peds.2012-1225","volume":"131","author":"H Srinivasalu","year":"2013","unstructured":"Srinivasalu H, Brescia AC, Rose CD. Lyme chondritis presenting as painless ear erythema. Pediatrics. 2013;131:1977\u201381.","journal-title":"Pediatrics."},{"key":"2377_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1097\/INF.0000000000000884","volume":"34","author":"M Arne\u017e","year":"2015","unstructured":"Arne\u017e M, Ru\u017ei\u0107-Sablji\u0107 E. Borrelial Lymphocytoma in Children. Pediatr Infect Dis J. 2015;34:1319\u201322.","journal-title":"Pediatr Infect Dis J"},{"key":"2377_CR6","first-page":"Doc 14","volume":"15","author":"H Hoffman","year":"2017","unstructured":"Hoffman H, et al. Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. Ger Med Sci. 2017;15:Doc 14. eCollection 2017.","journal-title":"Ger Med Sci"},{"key":"2377_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.0303-6987.2003.00167.x","volume":"31","author":"C Colli","year":"2004","unstructured":"Colli C, et al. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004;31:232\u201340.","journal-title":"J Cutan Pathol"},{"issue":"8","key":"2377_CR8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1468-3083.2006.01627.x","volume":"20","author":"K Aydogan","year":"2006","unstructured":"Aydogan K, et al. Borrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2A. J Eur Acad Dermatol Venereol. 2006;20(8):1030\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2377_CR9","doi-asserted-by":"publisher","first-page":"bcr2014205688","DOI":"10.1136\/bcr-2014-205688","volume":"2015","author":"MT Mohanna","year":"2015","unstructured":"Mohanna MT, Kamarashev J, Hofbauer GF. Borrelial pseudolymphoma of the nose. BMJ Case Rep. 2015;2015:bcr2014205688.","journal-title":"BMJ Case Rep"},{"issue":"11","key":"2377_CR10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S1473-3099(19)30287-7","volume":"19","author":"H Yildiz","year":"2019","unstructured":"Yildiz H, Marot L. Borrelial lymphocytoma of the lip. Lancet. 2019;19(11):1264.","journal-title":"Lancet."},{"key":"2377_CR11","first-page":"243","volume":"66","author":"B Chodynicka","year":"2000","unstructured":"Chodynicka B, et al. Lymphocytoma cutis: Cases linked with Lyme disease. Cutis. 2000;66:243\u20136.","journal-title":"Cutis."},{"issue":"6Pt1","key":"2377_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0190-9622(98)70154-9","volume":"38","author":"T Ploysangam","year":"1998","unstructured":"Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38(6Pt1):877\u201395.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2377_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/0128071-200809060-00002","volume":"9","author":"RR M\u00fcllegger","year":"2008","unstructured":"M\u00fcllegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol. 2008;9(6):355\u201368.","journal-title":"Am J Clin Dermatol"},{"key":"2377_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF02033059","volume":"20","author":"F Strle","year":"1992","unstructured":"Strle F, Pleterski-Rigler D, Stanek G, Pejovnik-Pustinek A, Ruzic E, Cimperman J. Solitary borrelial lymphocytoma: Report of 36 cases. Infection. 1992;20:201\u20136.","journal-title":"Infection."},{"issue":"4","key":"2377_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaad.2010.03.046","volume":"64","author":"C Bhate","year":"2011","unstructured":"Bhate C, Schwartz RA. Lyme disease: Part I. Advances and perspectives. J Am Acad Dermatol. 2011;64(4):619\u201336.","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-020-02377-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T03:06:18Z","timestamp":1722740778000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02377-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02377-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}